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Next-Generation Sequencing of a 40 Mb Linkage
Interval Reveals TSPAN12 Mutations in Patients
with Familial Exudative Vitreoretinopathy
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Familial exudative vitreoretinopathy (FEVR) is a genetically heterogeneous retinal disorder characterized by abnormal vascularisation of
the peripheral retina, often accompanied by retinal detachment. To date, mutations in three genes (FZD4, LRP5, and NDP) have been
shown to be causative for FEVR. In two large Dutch pedigrees segregating autosomal-dominant FEVR, genome-wide SNP analysis
identiﬁed an FEVR locus of ~40 Mb on chromosome 7. Microsatellite marker analysis suggested similar at risk haplotypes in patients
of both families. To identify the causative gene, we applied next-generation sequencing in the proband of one of the families, by
analyzing all exons and intron-exon boundaries of 338 genes, in addition to microRNAs, noncoding RNAs, and other highly conserved
genomic regions in the 40 Mb linkage interval. After detailed bioinformatic analysis of the sequence data, prioritization of all detected
sequence variants led to three candidates to be considered as the causative genetic defect in this family. One of these variants was an
alanine-to-proline substitution in the transmembrane 4 superfamily member 12 protein, encoded by TSPAN12. This protein has very
recently been implicated in regulating the development of retinal vasculature, together with the proteins encoded by FZD4, LRP5,
and NDP. Sequence analysis of TSPAN12 revealed two mutations segregating in ﬁve of 11 FEVR families, indicating that mutations
in TSPAN12 are a relatively frequent cause of FEVR. Furthermore, we demonstrate the power of targeted next-generation sequencing
technology to identify disease genes in linkage intervals.Familial exudative vitreoretinopathy (FEVR) is a well-char-
acterized hereditary ocular disorder that was ﬁrst described
by Criswick and Schepens.1 The pathologic features of the
disease initiate from the abnormal retinal development due
to the incomplete vascularization of the peripheral retina
and/or retinal blood vessel differentiation.2 The latter can
lead to various complications, such as retinal neovasculari-
zation and exudates, vitreous haemorrhage, ectopia of the
macula, retinal folds, and retinal detachment.3 FEVR is
genetically heterogeneous and shows autosomal-domi-
nant, autosomal-recessive, and X-linked recessive modes
of inheritance.1,4–9 Mutations in the genes coding for
frizzled 4 (FZD4, located on 11q14.2 [MIM *604579]) and
low-density lipoprotein 5 (LRP5, located on 11q13.2
[MIM *603506]), which act asWnt coreceptors, and Norrin
(NDP, located on Xp11.3 [MIM *300658]), a ligand for
these Wnt receptors, have been shown to result in FEVR.
A consistent feature is the aberrant retinal vascular devel-
opment caused by the impaired action of the Ndp/b-cate-
nin signaling pathway, which, among others, orchestrates
eye organogenesis and blood supply.7,10–13
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pating relatives in adherence to the tenets of the Declara-
tion of Helsinki. In 11 families with autosomal-dominant
FEVR, we excluded mutations in FZD4 and LRP5 via
sequence analysis of all coding exons and intron-exon
boundaries (unpublished data). In those families in which
X-linked inheritance could not be excluded on the basis of
the pattern of inheritance, mutations in NDP were
excluded via sequence analysis. In the two largest families
(families A and B) that did not carry exonic mutations in
FZD4 and LRP5, detailed analysis of microsatellite markers
surrounding these two genes excluded them as causative
for FEVR. Patients in both families invariably show a
peripheral avascular area, the most typical feature in
FEVR (Figure 1). The visual acuity varies considerably
(normal to light perception) as a result of secondary defects
such as retinal detachment and retinal exudates. Subse-
quently, eight individuals from family A and 15 individ-
uals from family B (Figure 2A) were genotyped on the
Inﬁnium II HumanLinkage-12 Panel (Illumina, San Diego,
CA, USA) that contains 6090 SNP markers. Genome-wide
linkage analysis via the GeneHunter 2.1r5 program in
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Figure 1. Fundus Photograph Showing Part of the Avascular
Periphery of Patient IV:2 from Family A
Temporal periphery of the left fundus in patient IV:2 from family
A (numbering according to the pedigree presented in Figure 2A).
The retinal vasculature (at the left side) ends in small aberrant
ramiﬁcations in the equatorial area of the fundus. The peripheral
retina (at the right side) is avascular; only choroidal vessels are
present in this area.a 40.5Mb genomic region on chromosome 7 suggestive for
linkage (LOD score 2.34) in family A (Figure 2B, left panel),
whereas in family B, a signiﬁcant LOD score of 3.31 was ob-
tained for a 16.7 Mb genomic region on chromosome 7
(Figure 2B, right panel), completely contained within the
40.5 Mb region detected in family A (Figure 3A). Moreover,
the affected individuals in both families shared the same
SNP andmicrosatellite alleles for a region of at least 10 Mb.
These results strongly suggested that the region on chro-
mosome 7 is likely to contain a gene causative for FEVR.
Two obvious candidate genes within the shared linkage
intervals were WNT2 (MIM *147870) and WNT16 (MIM
*606267), since the canonical Wnt signaling pathway has
been implicated in regulating the formation of intraretinal
capillaries.15 Sequence analysis of the exons and intron-
exon boundaries of these two genes in probands III-7
(family A) and II-5 (family B) did not, however, reveal
any sequence variant causative for FEVR.
Given the high number of genes in the region, as well as
the lack of other obvious candidate genes, we decided to
apply array-based sequence capture followed by next-
generation sequencing to simultaneously analyze all genes
in the region. The complete 40.5 Mb region on chromo-
some 7, suggestive for linkage in family A (Figure 3A, upper
panel), was used for sequence capture. The array design
included all known exons, untranslated regions (UTRs),
microRNAs, and highly conserved regions (PhastCons
Conserved Elements, 28-way Mammal Multiz Alignment,
LOD score R 100), complemented with the complete
genomic sequence of WNT2 and WNT16. For all exons,
an additional 30 base pairs (bp) were added at each sideThe Americafor the detection of splice-site mutations. Targets smaller
than 250 bp, which is, based upon our experience, the
minimum size for the DNA capture protocol, were enlarged
by extending both ends of the region. In total, 3048 exons
from 338 RefSeq genes and 313 UCSC genes (see Web
Resources), as well as 14 microRNAs and 23 noncoding
RNAs, were targeted (Figure S1, available online). Together
with the UTRs and regions of high conservation, 2,366,514
bp were selected. For reasons of efﬁciency, the array
included targets for another linkage region representing
352 Kb on chromosome 17. After stringent probe selection
by NimbleGen (Roche NimbleGen, Madison, WI, USA)
(uniqueness tested by Sequence Search and Alignment by
Hashing Algorithm-SSAHA),16 a total of 2,528,988 bases
were represented on an array, with 385,000 oligonucleo-
tide probes targeting the region of interest as well as the
additional region on chromosome 17.
Sequence capture was performed in accordance with the
manufacturer’s instructions (Roche NimbleGen). In brief,
20 mg of genomic DNA of the FEVR proband from family
Awas used in the preparation of DNA for sequence-capture
hybridization. A ﬁnal amount of 5 mg DNA was hybridized
to the customized array, subsequently eluted and ampliﬁed
by ligation-mediated PCR. Three micrograms of ampliﬁed
enriched DNA was used as input for generating an ssDNA
library for massive parallel sequencing, with the use of a
Roche 454 GS FLX sequencer with Titanium series re-
agents. The sample was sequenced by using one quarter
lane of a Roche sequencing run, yielding 48.6 Mb of
sequence data. Approximately 94.5% of the sequence
datamapped back to unique regions of the human genome
(hg18, NCBI Build 36.1), with the use of the Roche New-
bler software (version 2.0.01.12). Of all mapped reads,
90.5% was located on or near the targeted regions (i.e.,
within 500 bp proximity). This was sufﬁcient to reach an
average of 13.2-fold coverage of all target regions and,
more speciﬁcally, an average of 14.7-fold coverage of the
targeted exons on chromsome 7. For the region of interest,
only 5.2% (112,319 bp) of all targeted sequences were not
covered, whereas 39.2% (1,099,873 bp) of the target
sequence was covered less than ten times (Table S1).
The Roche software detected a total of 1915 variants on
chromosome 7. We used a custom-made data analysis
pipeline to annotate detected variants with various
kinds of information, including known SNPs, amino acid
consequences, genomic location, and evolutionary conser-
vation. With this analysis, 1749 variants were found to
correspond to known SNPs or to overlap with a known
polymorphic region (dbSNP130). After we excluded non-
exonic (145), synonymous (4), and putative homozygous
variants (variation percentage R 80%) (3), 14 variants
remained (Table 1). From these, three promising candi-
dates were selected (in the PTCD1, ZAN [MIM *602372],
and TSPAN12 [MIM *613138] genes) because they were
detected in at least four nonduplicate reads and had a
high score for evolutionary conservation (vertebrate
PhyloP).17–19n Journal of Human Genetics 86, 240–247, February 12, 2010 241
Figure 2. Pedigree Structure and Genome-wide Linkage Analysis for FEVR Families A and B
(A) Pedigree structure of those parts of families A and B that were selected for Illumina 6K SNP genotyping analysis. Individuals of whom
the clinical status is uncertain are depicted in gray. Probands are indicated with an arrow. Eight members of family A and 15 individuals
of family B, indicated with asterisks, were genotyped.
(B) Genome-wide LOD score calculations, with the use of the 6K SNP array genotyping data. In family A, two peaks are visible, on chro-
mosomes 7 and 8, respectively. In family B, only one clear peak is visible, on chromosome 7, with a genome-wide-signiﬁcant LOD score
of 3.31. Interestingly, the two peaks on chromosome 7 in families A and B, indicated by arrows, represent the same genomic region.The missense variant detected in PTCD1 changes an
arginine to a cysteine, whereas the variant in ZAN alters
an arginine to a histidine residue. Both arginine residues
are not completely conserved throughout vertebrate evolu-
tion. In addition, the presumed physiological roles of the
proteins encoded by PTCD1 and ZAN, namely controlling
leucine tRNA levels in mitochondria20 and regulating the
adhesion of sperm cells to the zona pellucida,21 respec-
tively, do not support their involvement in causing
FEVR. Finally, PTCD1 and ZAN are both located outside
the smaller linkage interval in family B and will therefore
deﬁnitely not be causative for FEVR in that family. The
TSPAN12 gene, however, is located within the shared
linkage interval, and the variant detected via next-genera-
tion sequencing technology substitutes a proline residue
for a highly conserved alanine residue, with the highest
PhyloP conservation score (Table 1). In addition, very
recently, TSPAN12 was found to regulate retinal vascular
development in cooperation with the proteins encoded
by FZD4, LRP5, and NDP.22 Therefore, the variant detected
in TSPAN12 was considered to be the mutation causative
for FEVR in family A.
TSPAN12 contains eight exons, for which exons 2–8 are
protein coding, plus an alternative noncoding exon for a
different isoform (Figure 3A). All exons of TSPAN12 were242 The American Journal of Human Genetics 86, 240–247, Februarycovered by sequence reads from the targeted next-genera-
tion sequencing experiment (Figure 3A). The missense
variant that was detected by this approach (c.709G>C
[p.Ala237Pro]) is located in exon 8. This exon was covered
by more than 30 sequence reads (Figure 3B). The mutated
nucleotide (at position 120,216,091) was covered by 20
unique sequence reads. In ten of the reads, the reference
allele was detected, whereas in the other ten reads, the
mutant allele was observed (Figure 3C), indicating that
the mutation is present in a heterozygous state.
Conventional Sanger sequencing conﬁrmed the muta-
tion to be present in the proband of family A, as well as
in the proband of family B who shared the at-risk haplo-
type for the region containing TSPAN12. Furthermore,
the mutation was present in all relatives that were clearly
affected with FEVR in both families (Figure S2). In three
other relatives of whom the clinical status was uncertain
(III:1 in family A, III:15 and IV:2 in family B) and in one
healthy individual (III:8 in family B), the mutation was
also present, which points to nonpenetrance, a feature
that is also often observed in FEVR families withmutations
in FZD4, LRP5, and NDP.3
To determine the prevalence of TSPAN12mutations as a
cause of FEVR, we selected nine additional FEVR probands
from unrelated families for sequence analysis of the12, 2010
Figure 3. Genomic Structure, Next-
Generation Sequencing, and Mutation
Analysis of TSPAN12
(A) Upper panel, part of chromosome 7
showing the linkage intervals and the cor-
responding ﬂanking SNPs for FEVR fami-
lies A and B. The linkage interval from
family A was enriched for targeted next-
generation sequencing technology. The
TSPAN12 gene is located in the shared
interval between families A and B. Lower
panel, overview of the genomic structure
of the TSPAN12 gene, showing all introns
and exons. For all exons, as well as a highly
conserved region between exons 7 and 8,
the sequence coverage histograms are
presented.
(B) Overview of all patient reads for exon 8
of TSPAN12. In total, more than 30 reads
were representing parts of this exon.
(C) Sequence traces for the twenty unique
reads covering the TSPAN12 heterozygous
G-to-C mutation. For these 20 reads,
ten were representing the reference
allele and ten were showing the mutant
allele. At the protein level, the G-to-C tran-
sition results in the substitution of a
proline for an alanine residue (c.709G>C
[p.Ala237Pro]).
(D) Topology of TSPAN12 and the posi-
tions of the missense mutions identiﬁed
in the FEVR families. TSPAN12 shows the
characteristic domain structure of tetraspa-
nins, including four transmembrane (TM)
domains (in green). A cysteine residue
preceding TM domain 1 (C9) and another
following TM domain 2 (C83) are probably
palmitoylated (bright green wavy lines).
The second extracellular loop (EC2)
contains three a helices (boxes), the
typical C-C-G motif characteristic for all
tetraspanin proteins, followed by one pair
and two single cysteine residues. These six
cysteines are predicted to form disulphide
bonds (stippled lines). The glycine residue
that is mutated into an arginine (G188)
precedes one of these cysteines. The alanine residue that is mutated into a proline (A237) resides within an a-helical structure within
the fourth TM region.
(E) Sequence comparison of a number of vertebrate TSPAN12 proteins. Depicted are parts of TSPAN12 that harbor the amino acid
residues that are mutated. Both the glycine residue at position 188 (upper panel) and the alanine residue at position 237 (lower panel)
are completely conserved throughout vertebrate evolution. Residues identical in all sequences are black on a white background, whereas
similar amino acids are black on a light gray background. Nonconservative changes are indicated in white on a black background.
UniProt accession number of the protein sequences used for sequence comparison are as follows: human TSPAN12, O95859; bovine
TSPAN12, Q29RH7; mouse TSPAN12, Q8BKT6; chicken TSPAN12, Q5ZIF5; zebraﬁsh TSPAN12, Q7T2G0.complete gene (primer sequences are listed in Table S2). In
two of these nine families, the same p.Ala237Pro change
was detected as segregating with the phenotype (families
C and D; Figure S2). Microsatellite marker analysis sur-
rounding TSPAN12 showed that the affected individuals
of all four families showed a shared at-risk haplotype of
at least 5.8 Mb (data not shown). In addition, a second
variant was detected in the proband of family E, sub-
stituting an arginine residue for a glycine residue
(c.562G>C [p.Gly188Arg]). This change was also present
in his affected brother (Figure S2). Both changes were not
detected in 140 ethnically matched control individuals
(data not shown), nor were they present in a databaseThe Americacontaining more than two million variants from various
in-house and published next-generation sequencing
projects.23–25 An overview of the mutations that were
identiﬁed is presented in Table 2.
The TSPAN12 protein is a member of the tetraspanin
family, whose members share certain speciﬁc structural
features that distinguish them from other proteins that
pass the membrane four times.26 The glycine residue at
position 188 is located in the extracellular loop between
the third and the fourth transmembrane region and is
completely conserved throughout vertebrate evolution
(Figures 3D and 3E). The arginine residue substituting the
glycine has a bulky side chain that is positively charged.n Journal of Human Genetics 86, 240–247, February 12, 2010 243
Table 1. Overview of All Nonsynonymous Sequence Variants Not Present in dbSNP
Position of the
Reference Allele
on Chr. 7
Reference
Allele
Variant
Allele
No. of
Reads
No. of
Variant reads
Variation
(%)
Reference
Amino Acid
Variant
Amino Acid Gene
PhyloP
Score
92570705 T C 7 3 43 D G SAMD9 1.56
98870495 G A 26 16 62 R C PTCD1 3.06
99835402 C T 13 6 46 P L PILRA 1.75
100122289 - CCT 5 3 60 EQ ERQ GIGYF1 3.98
100209410 G A 15 8 53 R H ZAN 1.81
100473466 A G 38 13 34 T A MUC17 0.60
105066159 TC - 19 3 16 E X ATXN7L1 4.92
113306419 C T 15 6 40 S N PPP1R3A 1.05
115411632 C T 14 5 36 D N TFEC 0.45
119702880 T C 29 3 10 C R KCND2 5.00
120216091 C G 20 10 50 A P TSPAN12 5.32
120555712 T C 10 3 30 L S C7orf58 3.00
128099699 C G 7 5 71 I M FAM71F2 0.42
128221650 T C 13 3 23 L P CCDC136 1.26
After initial filtering of the 1915 variants on the basis of overlap with dbSNP (build 130) and amino acid consequences, only 14 candidate variants remained. Vari-
ants marked in bold were selected after further prioritization on the basis of the number of variant reads and evolutionary conservation. The position of the refer-
ence base pair is based on UCSC Genome Browser build hg18. The table lists the reference allele and the variant allele for that position, the total number of high-
confidence sequence reads for this position, and the number of times that a variant was read. The percentage of variation indicates how often a variant was read in
comparison to the total number of reads. The amino acid of the reference and mutant alleles are indicated, as well as the gene in which the variant was detected. In
the right column, the vertebrate PhyloP score for evolutionary conservation is presented.17–19In addition, this small and ﬂexible glycine residue precedes
a cysteine residue that is involved in the formation of
disulphide bridges (Figure 3D) and is highly conserved in
the complete tetraspanin protein family.27 Therefore, the
substitution of an arginine for this glycine residue is likely
to affect TSPAN12 function. The alanine at position 237
resides within the fourth transmembrane region and is
also completely conserved throughout vertebrate evolu-
tion (Figures 3D and 3E). A proline residue has the intrinsic
property to induce bends in the three-dimensional protein
structure. Therefore, a proline residue at position 237 is
predicted to disrupt the helical structure of the transmem-
brane region, which would result in a TSPAN12 protein
with a defective conﬁrmation that might even be subjectTable 2. Overview of the Missense Mutations Identified in TSPAN12
Family Proband
No. of Affected Relatives
with the Mutation
No. of Unaffecte
Relatives with t
Family A III-7 3 0
Family B II-5 7 1
Family C II-2 0 0
Family D III-2 3 0
Family E II-1 1 0
Five families have been identified as carrying a dominant missense mutation in TS
each family, the number of affected relatives that carry the mutation is listed. In fa
trance. None of the two variants was detected in over 280 ethnically matched co
244 The American Journal of Human Genetics 86, 240–247, Februaryto proteolytic degradation. The p.Ala237Pro mutation
was detected in four unrelated Dutch families. Genealog-
ical analysis revealed, however, that the ancestors of fami-
lies A, B, and C were born in the same region in the eastern
part of The Netherlands, with those of families B and C
even being born in the same village. These data, combined
with the microsatellite marker analysis that showed a
shared haplotype among all families, suggest that the
p.Ala237Pro mutation is a regional founder mutation.
The TSPAN12 protein has recently been identiﬁed as
playing a crucial role in the regulation of the development
of the retinal vasculature.22 Mice lacking Tspan12 show
a primary vascular defect in the developing retina between
postnatal days 5 and 11, similar to the phenotypesd
he Mutation
Mutation
(cDNA Level)
Mutation
(Protein Level)
Frequency in
Control Alleles
c.709G>C p.Ala237Pro 0/280
c.709G>C p.Ala237Pro 0/280
c.709G>C p.Ala237Pro 0/280
c.709G>C p.Ala237Pro 0/280
c.562G>C p.Gly188Arg 0/280
PAN12. The proband corresponds to the pedigrees depicted in Figure S2. For
mily B, one healthy individual also carried the mutation, suggesting nonpene-
ntrol alleles.
12, 2010
described for Fzd4, Lrp5, and Ndphmutant mice, genes for
which mutations in the human orthologs also cause
FEVR.13,28,29 In addition, whereas heterozygous Tspan12,
Lrp5, and Ndph single-mutant mice did not show any
abnormalities, Tspan12/Lrp5 and Tspan12/Ndph double-
heterozygous mice demonstrated a retinal vascular pheno-
type, indicating that these proteins act in a similar
pathway. A series of dedicated experiments revealed that
TSPAN12 is required for Norrin-induced b-catenin
signaling, by promoting FZD4 multimerization and
clustering of FZD4 via binding to Norrin multimers.22
A question that remains is how the heterozygous FEVR-
mutations described in this study affect the function of
TSPAN12 and the complex that it is associated with. The
glycine residue at position 188 precedes a highly conserved
cysteine among tetraspanin family members involved in
the formation of disulﬁde bridges and is located in the
large extracellular loop (EC2) between the third and fourth
transmembrane region (Figure 3D). This extracellular loop
is known to harbor most of the protein-protein interaction
sites described for tetraspanins.30 As such, the substitution
of an arginine residue for the glycine at position 188might
disrupt one of these interactions; for instance, the interac-
tion with the Fzd4/Lrp5/Norrin protein complex. The
alanine-to-proline change at position 237 is likely to
disrupt the three-dimensional structure of TSPAN12.
Both haploinsufﬁciency and a dominant-negative effect
of the mutant TSPAN12 on the wild-type protein should
be considered as the underlying disease mechanism.
Tetraspanins are suggested to form so-called tetraspanin-
enriched microdomains that act as speciﬁc signaling
compartments within the membrane and might form
homomultimers, as well as protein complexes, with nonte-
traspanin membrane proteins.30,31 In the case that
TSPAN12 indeed forms homomultimers, the two missense
mutations that cause FEVR might impair multimerization
of the protein and, as such, act in a dominant-negative
fashion. This would be in line with the absence of any
abnormalities in the heterozygous Tspan12 mutant
mice.22 Recessive loss-of-function mutations in genes
encoding other tetraspanins, such as TM4SF2 (MIM
*300096) and CD151 (MIM *602243), causing X-linked
mental retardation and kidney malfunctions, respectively,
would favor a dominant-negative mechanism instead of
haploinsufﬁciency.32,33 On the other hand, heterozygous
loss-of-function mutations in the PRPH2 gene [MIM
*179605], encoding the tetraspanin peripherin, cause auto-
somal-dominant retinal photoreceptor degeneration,
favoring a model for haploinsufﬁciency.34,35 Additional
functional studies are needed to determine the effect of
the two missense mutations described here, in order to
unravel the pathological mechanism in which dominant
mutations in TSPAN12 are causative for FEVR.
This study shows the power of next-generation
sequencing after initial identiﬁcation of a disease-gene
locus. So far, the only other example of this approach
has been reported on by Brkanac et al., which led to theThe Americaidentiﬁcation of IFRD1 (MIM *603502) as a candidate
gene for autosomal-dominant sensory and motor neurop-
athy with ataxia (MIM %607458).36 This targeted rese-
quencing approach may be an attractive alternative to
whole-genome or -exome resequencing in those families
for which disease loci have been deﬁned. Recently, unbi-
ased genome-wide resequencing of the whole human
exome led to the ﬁrst disease-gene identiﬁcation in
patients with Miller syndrome.37 The number of potential
protein-truncating variants in their study was, however,
approximately three orders of magnitude higher than
those identiﬁed by our study. Such a genome-wide
approach requires multiple affected individuals to limit
the amount of potential candidate genes, especially
when operating under an autosomal-dominant disease
model.
In conclusion, we have identiﬁed TSPAN12 as a gene
causative for autosomal-dominant FEVR. TSPAN12 is
only the third autosomal gene described to be causative
for FEVR and is mutated in ﬁve of the 11 Dutch families
studied. On the basis of the function of TSPAN12 in regu-
lating the development of the retinal vascular system, it is
expected that mutations in TSPAN12 will also be causative
in FEVR patients from different populations and, as such,
will facilitate genetic diagnostics for FEVR. Moreover, we
have proven the enormous power of next-generation
sequencing technology in combination with array-based
sequence capture, by identifying a single causative base-
pair substitution within a 40 Mb region containing more
than 300 genes. Given that for many inherited disorders,
several loci have been published for which the causative
gene still awaits discovery, applying this technology will
be instrumental in identifying many disease genes in the
near future.Supplemental Data
Supplemental Data include two ﬁgures and two tables and can be
found with this article online at http://www.ajhg.org.Acknowledgments
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